Bart Smets
Janssen R&D
Beerse, VLG, Belgium
Beerse, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Human CSF proteogenomics links genetic variation to neurodegenerative disease proteins.
Journal: medRxiv : the preprint server for health sciences
Published: February 27, 2026
CSF turnover reshapes biomarker interpretation in neurodegeneration studies.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease.
Journal: Nature aging
Published: October 03, 2025
The evolution of Alzheimer's target identification: Towards a fusion of artificial and cellular intelligence.
Journal: The journal of prevention of Alzheimer's disease
Published: September 05, 2025
Proteomic signatures of the APOE ε4 and APOE ε2 genetic variants and Alzheimer's disease.
Journal: medRxiv : the preprint server for health sciences
Published: August 13, 2025
Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,170 people.
Journal: medRxiv : the preprint server for health sciences
Published: July 09, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging.
Journal: Nature medicine
Published: April 24, 2025
A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia.
Journal: Nature medicine
Published: April 18, 2025
Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort.
Journal: International journal of molecular sciences
Published: October 29, 2024
Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants.
Journal: Molecular neurodegeneration
Published: June 09, 2023
Last Updated: 09/26/2026